NYSE:OCX
Delisted

Oncocyte Stock Forecast

etoro logo Buy OCX
*Your capital is at risk
$3.20
+0 (+0%)
At Close: Sep 16, 2025

OCX Performance

FAQ

What is the symbol for OncoCyte Corp Stock and on which exchange is it traded?
The symbol for OncoCyte Corp is OCX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell OncoCyte Corp Stock?
OncoCyte Corp holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy OncoCyte Corp Stock?
OncoCyte Corp Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy OncoCyte Corp Stock.

What's the current price of OncoCyte Corp Stock?
As of the end of day on the Sep 16, 2025, the price of an OncoCyte Corp (OCX) share was $3.20.

What is the 52-week high and low for OncoCyte Corp Stock?
The 52-week high for OncoCyte Corp Stock is $4.75 and the 52-week low is $1.92.

What is the market capitalization of OncoCyte Corp Stock?
As of the Sep 16, 2025, the market capitalization of OncoCyte Corp is 91.518M.
Click to get the best stock tips daily for free!
ABOUT ONCOCYTE CORP
OncoCyte
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE